Key Details
Price
$70.49Last Dividend
$0.52Annual ROE
11.29%Beta
0.04Events Calendar
Next earnings date:
Jan 31, 2025Recent quarterly earnings:
Oct 31, 2024Recent annual earnings:
Feb 01, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 13, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
LOUISVILLE, Ky., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (NASDAQ: CREX, CREXW), a top provider of digital signage and media solutions, is sharing the impressive progress and transformative effects of its specially designed digital menu board CMS platform, Clarity™.
On November 8, 2024, in Jackson, Michigan, the CMS Energy Board of Directors announced a dividend for the Series C 4.200% Cumulative Redeemable Perpetual Preferred Stock.
On November 8, 2024, in Jackson, Michigan, the Board of Directors at Consumers Energy, which is the main subsidiary of CMS Energy, announced a quarterly dividend for the Utility's preferred stock.
Myomo's business model has become sustainable because CMS has reclassified MyoPro, resulting in one-time payments and steady insurance coverage. The improvements in Medicare Part B coverage have boosted Myomo's profit margins and increased product sales. Additionally, creating a network of Orthopedic and Prosthetic clinics will reduce the costs of gaining new customers and lead to ongoing sales, supporting long-term growth and profitability.
MELBOURNE, Australia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX) is pleased to announce that the U.S. Centers for Medicare & Medicaid Services (CMS) will now provide separate payments for specialized diagnostic radiopharmaceuticals for Medicare Fee for Service patients in hospital outpatient settings, even after the transitional pass-through payment period. This important decision will improve access to advanced imaging agents for all patients and hospitals in the future.
The Symplicity™ blood pressure procedure provides a new method for patients to reduce their blood pressure. Medtronic plc announced that the Centers for Medicare & Medicaid Services (CMS) has approved transitional pass-through (TPT) payment for the Symplicity Spyral™ renal denervation catheter, which will start on January 1, 2025, and last for three years. This payment aims to improve patient access to innovative technologies, including those recognized as Breakthrough Devices.
On November 1, 2024, HeartCore Enterprises, Inc. (Nasdaq: HTCR), a top software and data consulting firm located in Tokyo, announced a correction to a figure mentioned in the second paragraph of its press release from October 30, 2024.
While the revenue and earnings per share (EPS) for CMS Energy (CMS) provide insight into its performance for the quarter ending September 2024, it could be helpful to look at how these important figures stack up against Wall Street predictions and last year's results.
CMS Energy Corporation (NYSE:CMS) will hold its Q3 2024 Earnings Conference Call on October 31, 2024, at 9:30 AM ET. Key company participants include Jason Shore, Garrick Rochow, and Rejji Hayes. The earnings release and presentation for this call can be found on the CMS Energy website under the Investor Relations section.
CMS Energy (CMS) reported quarterly earnings of $0.84 per share, which is higher than the Zacks Consensus Estimate of $0.78 per share. This is an increase compared to earnings of $0.61 per share from the same time last year.
FAQ
- What is the primary business of CMS Energy?
- What is the ticker symbol for CMS Energy?
- Does CMS Energy pay dividends?
- What sector is CMS Energy in?
- What industry is CMS Energy in?
- What country is CMS Energy based in?
- When did CMS Energy go public?
- Is CMS Energy in the S&P 500?
- Is CMS Energy in the NASDAQ 100?
- Is CMS Energy in the Dow Jones?
- When was CMS Energy's last earnings report?
- When does CMS Energy report earnings?
- Should I buy CMS Energy stock now?